Members from Danaher Diagnostics provided clinical commentary and insights on an emerging immunoassay geared towards testing apolipoprotein (APOE) in patients with suspected Alzheimer disease.
Jeremiah Hinson, MD, PhD
Advertisement
Chief Scientific Officer, Neurodegenerative Disease, Danaher Diagnostics
Articles by Jeremiah Hinson, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
The Expanding Role of Blood-Based Biomarkers in Alzheimer Disease
2
Beyond AAV: How Extracellular Vesicles Are Opening a New Chapter in Duchenne Gene Therapy
3
The Role of Cerebrospinal Fluid in Personalized Alzheimer Disease Care: Betty Tijms, PhD
4
Advances in Fragile X Syndrome Therapeutics: Overviewing the Pipeline
5